Cargando…

Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice

Activation of the Ras/MAPK pathway is prevalently involved in the occurrence and development of hepatocellular carcinoma (HCC). However, its effects on the deregulated cellular metabolic processes involved in HCC in vivo remain unknown. In this study, a mouse model of HCC induced by hepatocyte‐speci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Tingting, Rong, Zhuona, Dong, Jianyi, Li, Juan, Wang, Kangwei, Wang, Xinxin, Li, Huiling, Chen, Jun, Wang, Fujin, Wang, Jingyu, Wang, Aiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633588/ https://www.ncbi.nlm.nih.gov/pubmed/28941178 http://dx.doi.org/10.1002/cam4.1177

Ejemplares similares

Role of the Mitochondrial Citrate-malate Shuttle in Hras12V-Induced Hepatocarcinogenesis: A Metabolomics-Based Analysis
por: Lei, Chuanyi, et al.
Publicado: (2020)

Omics-Based Identification of Shared and Gender Disparity Routes in Hras12V-Induced Hepatocarcinogenesis: An Important Role for Dlk1-Dio3 Genomic Imprinting Region
por: Zhang, Jing, et al.
Publicado: (2021)

Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis
por: Li, Huiling, et al.
Publicado: (2020)

Evaluation of gaseous concentrations, bacterial diversity and microbial quantity in different layers of deep litter system
por: Li, Jing, et al.
Publicado: (2017)

Establishment of HRAS(G12V) Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs
por: Matsuzaki, Yuriko, et al.
Publicado: (2013)

Mycoplasma hyorhinis infection promotes gastric cancer cell motility via β‐catenin signaling
por: Liu, Xia, et al.
Publicado: (2019)

Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity
por: Smith, Alison E., et al.
Publicado: (2023)

DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2019)

Evaluation on reprogramed biological processes in transgenic maize varieties using transcriptomics and metabolomics
por: Fu, Wei, et al.
Publicado: (2021)

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
por: Bai, Kun‐Hao, et al.
Publicado: (2020)

MicroRNA-4651 represses hepatocellular carcinoma cell growth and facilitates apoptosis via targeting FOXP4
por: Li, Yun, et al.
Publicado: (2020)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

Comparison of Effects of p53 Null and Gain-of-Function Mutations on Salivary Tumors in MMTV-Hras Transgenic Mice
por: Jiang, Dadi, et al.
Publicado: (2015)

High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients
por: Chang, Boyang, et al.
Publicado: (2018)

Somatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal Nevi
por: Levinsohn, Jonathan L., et al.
Publicado: (2013)

Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Qingqing, et al.
Publicado: (2020)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network
por: Wang, Zhihui, et al.
Publicado: (2021)

Optimization of screening strategies for colorectal cancer based on fecal DNA and occult blood testing
por: Yao, Tingting, et al.
Publicado: (2023)

Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis
por: Fang, Qin-Liang, et al.
Publicado: (2020)

mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
por: Feng, Jing, et al.
Publicado: (2020)

Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Chen, Junhui, et al.
Publicado: (2021)

WDR76 regulates 5-fluorouracil sensitivity in colon cancer via HRAS
por: Hu, Yunlong, et al.
Publicado: (2023)

LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway
por: Zhang, Quan, et al.
Publicado: (2020)

The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
por: Wan, Xiaohua, et al.
Publicado: (2017)

Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma
por: Ding, Yuan, et al.
Publicado: (2020)

Integrated metabolomic and transcriptomic analyses reveal different metabolite biosynthesis profiles of Juglans mandshurica in shade
por: Zhang, Xinxin, et al.
Publicado: (2022)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

Rac1 and Cdc42 are regulators of HRas(V12)-transformation and angiogenic factors in human fibroblasts
por: Appledorn, Daniel M, et al.
Publicado: (2010)

Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
por: Huang, Lu, et al.
Publicado: (2015)

Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
por: Nandi, Sayantan, et al.
Publicado: (2022)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma
por: Song, Ci, et al.
Publicado: (2016)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Mechanism of the Exchange Reaction in HRAS from Multiscale Modeling
por: Kapoor, Abhijeet, et al.
Publicado: (2014)

HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016)

Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation
por: Martin, R.J., et al.
Publicado: (2017)

Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects
por: Zhang, Sheng, et al.
Publicado: (2020)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l6jm729r437l9bh34v3tgvqivr